Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 32 (10) , 1434-1446
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (TL1TR001880, T32GM008275, GM110174, AI118891, CA196539, P01CA196539, 5K12CA076931)
- Leukemia and Lymphoma Society Robert Arceci Scholar award
- University of Pennsylvania Perelman School of Medicine Department of Pathology and Laboratory Medicine Institutional Startup Funds
This publication has 48 references indexed in Scilit:
- A quantitative atlas of histone modification signatures from human cancer cellsEpigenetics & Chromatin, 2013
- Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric GlioblastomaScience, 2013
- The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expressionGenes & Development, 2013
- Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problemsActa Neuropathologica, 2012
- Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor OutcomeAnnals of Surgery, 2009
- EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing PluripotencyMolecular Cell, 2008
- Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencingThe EMBO Journal, 2006
- Suz12 is essential for mouse development and for EZH2 histone methyltransferase activityThe EMBO Journal, 2004
- Partitioning and Plasticity of Repressive Histone Methylation States in Mammalian ChromatinMolecular Cell, 2003
- A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipidsAnalytical Biochemistry, 1984